← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 12, 2019Last known activity
Oct 31, 2024
Timeline
2010s
- Jun 1, 2012
Cingulate Therapeutics— Founded
Drugs by trial phase (1 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Recent trials (10)
- NCT07119073OfficialPhase 1Oct 31, 2024
- NCT07119073Lead sponsorPhase 1Oct 31, 2024
- NCT05924594Study directorPhase 3Jul 31, 2023
- NCT05924594Lead sponsorPhase 3Jul 31, 2023
- NCT05286762Lead sponsorPhase 3Jun 1, 2023
- NCT05286762Study directorPhase 3Jun 1, 2023
- NCT05631626Lead sponsorPhase 3Dec 31, 2022
- NCT04449250Lead sponsorPhase 1Feb 1, 2021
- NCT04449250Study directorPhase 1Feb 1, 2021
- NCT04138498Lead sponsorPhase 1/Phase 2Nov 12, 2019
Details
- Founded
- Kansas City, KS, US Jun 1, 2012
- Last known activity
- Oct 31, 2024